FDA Approves CALCIUM GLUCONATE — Caplin Steriles Limited
# FDA Approves Caplin Steriles Limited's Intravenous Calcium Gluconate Generic The FDA has approved Caplin Steriles Limited's abbreviated new drug application for intravenous calcium gluconate monohydrate (ANDA218840), expanding the competitive generic landscape for this essential electrolyte replacement therapy used in critical care and emergency settings. The approval is expected to increase treatment accessibility and potentially reduce healthcare costs for hospitals and patients requiring intravenous calcium supplementation.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day